Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
Clinical trial NCT02752685 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02752685
- Sponsor
- NYU Langone Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2022-12-29
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.